This site uses cookies to provide you with a more responsive and personalised service. By using this site you agree to our use of cookies. Please read our cookie notice for more information on the cookies we use and how to delete or block them.

Bookmark Email Print page


    Page   1/2   
  • Corruption Risk in the Chinese Pharmaceutical Market
    This Deloitte report examines how business can prepare for and address corruption risk in the Chinese pharmaceutical market.
  • Deloitte survey: Financial institutions increasing their focus and resources on risk management
    DTTL’s eighth biennial survey of CROs from 86 financial institutions. Gauges the risk management programs, planned improvements, and continuing challenges among global financial institutions.
  • Global Capital Markets Perspective - Issue 3
    This report studies the impact of global events on key instruments and geographies in the second half of 2012, from an issuer’s perspective.
  • Page   1/2   
Stay connected:

Material on this website is © 2014 Deloitte Global Services Limited, or a member firm of Deloitte Touche Tohmatsu Limited, or one of their affiliates. See Legal for copyright and other legal information.

Deloitte refers to one or more of Deloitte Touche Tohmatsu Limited, a UK private company limited by guarantee, and its network of member firms, each of which is a legally separate and independent entity. Please see for a detailed description of the legal structure of Deloitte Touche Tohmatsu Limited and its member firms.

More on Deloitte
Learn about our site